Literature DB >> 26619911

Repeated low-dose organophosphate DFP exposure leads to the development of depression and cognitive impairment in a rat model of Gulf War Illness.

Kristin F Phillips1, Laxmikant S Deshpande2.   

Abstract

Approximately 175,000-250,000 of the returning veterans from the 1991 Persian Gulf War exhibit chronic multi-symptom illnesses that includes neurologic co-morbidities such as depression, anxiety and cognitive impairments. Amongst a host of causative factors, exposure to low levels of the nerve agent Sarin has been strongly implicated for expression of Gulf War Illness (GWI). Nerve agents similar to pesticides are organophosphate (OP) compounds. There is evidence from civilian population that exposure to OPs such as in agricultural workers and nerve agents such as the survivors and first-responders of the Tokyo subway Sarin gas attack suffer from chronic neurological problems similar to GWI symptoms. Given this unique chemical profile, OPs are ideal to study the effects of nerve agents and develop models of GWI in civilian laboratories. In this study, we used repeated low-dose exposure to OP agent diisopropyl fluorophosphate (DFP) over a 5-day period to approximate the duration and level of Sarin exposure during the Persian Gulf War. We tested the rats at 3-months post DFP exposure. Using a battery of behavioral assays, we observed the presence of symptoms of chronic depression, anxiety and memory problems as characterized by increased immobility time in the Forced Swim Test, anhedonia in the Sucrose Preference Test, anxiety in the Elevated Plus Maze, and spatial memory impairments in the Object Location Test, respectively. Chronic low dose DFP exposure was also associated with hippocampal neuronal damage as characterized by the presence of Fluoro-Jade staining. Given that OP exposure is considered a leading cause of GWI related morbidities, this animal model will be ideally suited to study underlying molecular mechanisms for the expression of GWI neurological symptoms and identify drugs for the effective treatment of GWIs.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anxiety; DFP; Depression; Gulf War Illness; Memory impairments; Organophosphate

Mesh:

Substances:

Year:  2015        PMID: 26619911     DOI: 10.1016/j.neuro.2015.11.014

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  26 in total

1.  Pharmacologically increasing microtubule acetylation corrects stress-exacerbated effects of organophosphates on neurons.

Authors:  Anand N Rao; Ankita Patil; Zachary D Brodnik; Liang Qiang; Rodrigo A España; Kimberly A Sullivan; Mark M Black; Peter W Baas
Journal:  Traffic       Date:  2017-05-25       Impact factor: 6.215

2.  Inducible nitric oxide synthase inhibitor, 1400W, mitigates DFP-induced long-term neurotoxicity in the rat model.

Authors:  Marson Putra; Shaunik Sharma; Meghan Gage; Grace Gasser; Andy Hinojo-Perez; Ashley Olson; Adriana Gregory-Flores; Sreekanth Puttachary; Chong Wang; Vellareddy Anantharam; Thimmasettappa Thippeswamy
Journal:  Neurobiol Dis       Date:  2019-03-30       Impact factor: 5.996

Review 3.  Role of the calcium plateau in neuronal injury and behavioral morbidities following organophosphate intoxication.

Authors:  Laxmikant S Deshpande; Robert E Blair; Kristin F Phillips; Robert J DeLorenzo
Journal:  Ann N Y Acad Sci       Date:  2016-06-21       Impact factor: 5.691

4.  Rapid quantification of two chemical nerve agent metabolites in serum.

Authors:  Michael Kammer; Amanda Kussrow; Melissa D Carter; Samantha L Isenberg; Rudolph C Johnson; Robert H Batchelor; George W Jackson; Darryl J Bornhop
Journal:  Biosens Bioelectron       Date:  2019-01-31       Impact factor: 10.618

5.  The chemical convulsant diisopropylfluorophosphate (DFP) causes persistent neuropathology in adult male rats independent of seizure activity.

Authors:  Eduardo A González; Alexa C Rindy; Michelle A Guignet; Jonas J Calsbeek; Donald A Bruun; Ashish Dhir; Peter Andrew; Naomi Saito; Douglas J Rowland; Danielle J Harvey; Michael A Rogawski; Pamela J Lein
Journal:  Arch Toxicol       Date:  2020-04-18       Impact factor: 5.153

Review 6.  Novel therapeutics for treating organophosphate-induced status epilepticus co-morbidities, based on changes in calcium homeostasis.

Authors:  Laxmikant S Deshpande; Robert J DeLorenzo
Journal:  Neurobiol Dis       Date:  2019-03-12       Impact factor: 5.996

7.  Curcumin treatment leads to better cognitive and mood function in a model of Gulf War Illness with enhanced neurogenesis, and alleviation of inflammation and mitochondrial dysfunction in the hippocampus.

Authors:  M Kodali; B Hattiangady; G A Shetty; A Bates; B Shuai; A K Shetty
Journal:  Brain Behav Immun       Date:  2018-02-15       Impact factor: 7.217

8.  Pharmacological blockade of the calcium plateau provides neuroprotection following organophosphate paraoxon induced status epilepticus in rats.

Authors:  Laxmikant S Deshpande; Robert E Blair; Beverly A Huang; Kristin F Phillips; Robert J DeLorenzo
Journal:  Neurotoxicol Teratol       Date:  2016-05-17       Impact factor: 3.763

Review 9.  Gulf War Illness: Mechanisms Underlying Brain Dysfunction and Promising Therapeutic Strategies.

Authors:  Brandon Dickey; Leelavathi N Madhu; Ashok K Shetty
Journal:  Pharmacol Ther       Date:  2020-10-24       Impact factor: 12.310

10.  Vagus Nerve Stimulation Ameliorates Cognitive Impairment and Increased Hippocampal Astrocytes in a Mouse Model of Gulf War Illness.

Authors:  Lavanya Venkatasamy; Damir Nizamutdinov; Jaclyn Jenkins; Lee A Shapiro
Journal:  Neurosci Insights       Date:  2021-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.